Risedronate Prevents Bone Loss in Breast Cancer Survivors: A 2-Year, Randomized, Double-Blind, Placebo-Controlled Clinical Trial

PURPOSE: Limited data are available on the efficacy of oral bisphosphonate therapy in breast cancer survivors. Our goal was to examine prevention of breast cancer–related bone loss in this cohort. PATIENTS AND METHODS: Eighty-seven postmenopausal women after chemotherapy for breast cancer were rando...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Greenspan, Susan L., Brufsky, Adam, Lembersky, Barry C., Bhattacharya, Rajib, Vujevich, Karen T., Perera, Subashan, Sereika, Susan M., Vogel, Victor G.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2008
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3992822/
https://ncbi.nlm.nih.gov/pubmed/18427147
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2007.15.2967
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk